Browsing by Author "Aktas, Burak Yasin"

Now showing items 1-2 of 2

Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapy

Yildirim, Hasan Cagri; Guven, Deniz Can; Aktepe, Oktay Halit; Taban, Hakan; Yilmaz, Feride; Yasar, Serkan; Aktas, Burak Yasin; Guner, Gurkan; Dizdar, Omer; Aksoy, Sercan; Erman, Mustafa; Yalcin, Suayib; Kilickap, Saadettin (Kare Publishing, 2022)

Objectives: Although immune checkpoint inhibitors (ICIs) became a vital part of cancer care, many patients do not respond to treatment. In this group, a few of the patients with a hyperprogressive disease (HPD) have shorter ...
Pazopanib-induced chylothorax in a patient with renal cell carcinoma

Koylu, Bahadir; Tekin, Fatih; Aktas, Burak Yasin; Kilickap, Saadettin; Koksal, Deniz (Wolters Kluwer, 2022)

Pazopanib is an oral multi-kinase inhibitor approved for the treatment of advanced renal cell carcinoma (RCC). It is an anti-angiogenic agent, which blocks the activation signaling pathways of tyrosine kinases and prevents ...